)
Jui-Hao Lee, PhD
Director
Everfront Biotech Inc.
I am Adrian (Jui-Hao Lee), Director of Medical Affairs and spokesperson at Everfront Biotech. I received my Ph.D. through Academia Sinica and National Yang Ming Chiao Tung University in Taipei, Taiwan. My academic training in translational medicine focused on developing protein-based therapeutics and addressing key disease mechanisms, including osteoclast cell fusion and cancer cell fusion. This work shaped my commitment to translating molecular and cellular research into meaningful therapeutic products.
Building on its clinical progress and research foundation, Everfront Biotech has established a strong development pipeline. The company is advancing a local sustained-delivery approach designed to release a targeted small molecule for diseases characterized by biological barriers and complex heterogeneity, including brain and pancreatic tumors. Everfront’s primary focus is neuro-oncology and oncology, particularly high unmet-need diseases such as glioblastoma, while also expanding its efforts into pancreatic cancer.
Sessions
-
24-Jun-2026Theater 4Everfront Biotech Inc.
)
)
){kind=logo}
){kind=logo}
)
)
){kind=logo}
){kind=logo}